Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link

doi:10.3748/wjg.v28.i3.310

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10374)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

751

WORD

174

HTML

6273

Figures (1-3)

483

Tables (1-3)

511

Sum=8192

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

269

Download

511

Sum=780

Publishing Process of This Article

Item

Count

Browse

506

Download

896

Sum=1402

Jan 21, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 21, 2022; 28(3): 310-331
Published online Jan 21, 2022. doi: 10.3748/wjg.v28.i3.310

Full Size Figure Download Figure

Figure 2 Proposed algorithm for hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients based on the latest guidelines. HCC: Hepatocellular carcinoma; NAFLD: Non-alcoholic fatty liver disease; US: Ultrasonography; AFP: Alpha-fetoprotein; CT: Computer tomography; MRI: Magnetic resonance imaging; BMI: Body mass index.

Citation: Chrysavgis L, Giannakodimos I, Diamantopoulou P, Cholongitas E. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World J Gastroenterol 2022; 28(3): 310-331
URL: https://www.wjgnet.com/1007-9327/full/v28/i3/310.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i3.310